Print
Step 1. Check your state's specific lead-testing requirements
Who should be tested?
The Centers for Medicare and Medicaid Services (CMS) currently requires universal screening of Medicaid-covered one- and two-year olds. Children ages 36 to 72 months must also receive a blood-lead test if they have not been previously tested. Some states require universal testing in addition to testing all Medicaid children, while others require universal testing for children residing in zip codes with a large percentage of older housing built before 1978. New York also requires screening of pregnant women.
How do I know whether there are special requirements for blood-lead testing?
The LeadCare II blood-lead test is a CLIA-waived system. All facilities that use the system to perform blood-lead tests must have a CLIA Certificate of Waiver (see Step 2). Some states have additional registration, reporting, or proficiency requirements for users. Please contact your state lead-poisoning-prevention program for the latest regulations and requirements (click on the map to access the CDC's listing of state programs nationwide). If you are in California or New York, you can find additional information by following the menu-bar links on the left of this page.
Take Action!
We can meet the Healthy People goal to eliminate childhood lead poisoning. But we all need to be advocates with city, state, and federal officials to help ensure that every at-risk child has access to rapid blood-lead testing:
- State Medicaid plans must ensure that healthcare practitioners receive adequate reimbursement for blood-lead screening and follow-up services
- Managed care contracts and state policies should be amended to require plans to offer point-of-care blood-lead testing to at-risk children outside of capitation fee schedules, if necessary
- Federally Qualified Health Centers and others that serve low-income children need funding to ensure that all children can receive point-of-care blood-lead testing
- Restrictive state regulations governing laboratories, blood-lead testing, and reporting need to be updated to support in-office and community-based testing made possible by the FDA clearance of the CLIA-waived blood-lead-testing device
To purchase a LeadCare II system, call (800) 305.0197
To request details on the LeadCare II test:
Doctors click here
Public health click here